open access

Vol 14, No 6 (2019)
Case Reports
Published online: 2019-12-31
Get Citation

Pulmonary embolism in patients after central nervous system haemorrhage — is it possible to optimise antithrombotic therapy?

Kamil Klimczyk, Iwona Gorczyca, Justyna Tracz, Anita Rosołowska, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2019.0111
·
Folia Cardiologica 2019;14(6):593-597.

open access

Vol 14, No 6 (2019)
Case Reports
Published online: 2019-12-31

Abstract

We here present descriptions of two patients who after bleeding to the central nervous system sustained pulmonary
embolisms, and we discuss the therapeutic difficulties connected with the choice of safe antithrombotic treatment in
acute pulmonary embolism.

Abstract

We here present descriptions of two patients who after bleeding to the central nervous system sustained pulmonary
embolisms, and we discuss the therapeutic difficulties connected with the choice of safe antithrombotic treatment in
acute pulmonary embolism.

Get Citation

Keywords

haemorrhage, antithrombotic therapy, vascular malformation, pulmonary embolism

About this article
Title

Pulmonary embolism in patients after central nervous system haemorrhage — is it possible to optimise antithrombotic therapy?

Journal

Folia Cardiologica

Issue

Vol 14, No 6 (2019)

Pages

593-597

Published online

2019-12-31

DOI

10.5603/FC.2019.0111

Bibliographic record

Folia Cardiologica 2019;14(6):593-597.

Keywords

haemorrhage
antithrombotic therapy
vascular malformation
pulmonary embolism

Authors

Kamil Klimczyk
Iwona Gorczyca
Justyna Tracz
Anita Rosołowska
Beata Wożakowska-Kapłon

References (11)
  1. Bounameaux H, Perrier A. Diagnostic approaches to suspected deep vein thrombosis and pulmonary embolism. Hematol J. 2003; 4(2): 97–103.
  2. White RH. The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1): I4–I8.
  3. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008; 28(3): 370–372.
  4. Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007; 98(4): 756–764.
  5. Becattini C, Vedovati MC, Ageno W, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008; 117(1): 93–102.
  6. Konstantinides SV, Meyer G, Becattini C, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2019 [Epub ahead of print].
  7. Gabriel RA, Kim H, Sidney S, et al. Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010; 41(1): 21–26.
  8. Sayama CM, Osborn AG, Chin SS, et al. Capillary telangiectasias: clinical, radiographic, and histopathological features. Clinical article. J Neurosurg. 2010; 113(4): 709–714.
  9. Tang SC, Jeng JS, Liu HM, et al. Diffuse capillary telangiectasia of the brain manifested as a slowly progressive course. Cerebrovasc Dis. 2003; 15(1-2): 140–142.
  10. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006; 37(1): 256–262.
  11. Cossette B, Pelletier ME, Carrier N, et al. Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative. Ann Pharmacother. 2010; 44(6): 994–1002.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl